Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-25-004841
Filing Date
2025-05-07
Accepted
2025-05-07 14:36:09
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 27706
2 filename2.txt TEXT-EXTRACT 1173
  Complete submission text file 0000000000-25-004841.txt   40369
Mailing Address 37 DEREH MENACHEM BEGIN ST. 15TH FLOOR TEL AVIV Israel
Business Address 37 DEREH MENACHEM BEGIN ST. 15TH FLOOR TEL AVIV Israel 972 (0) 3 7326616
Enlivex Therapeutics Ltd. (Filed for) CIK: 0001596812 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: UPLOAD | File No.: 333-286956
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)